Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$401.2 - $581.79 $6,419 - $9,308
-16 Reduced 1.95%
805 $332,000
Q2 2023

Aug 14, 2023

SELL
$500.0 - $659.0 $11,000 - $14,498
-22 Reduced 2.61%
821 $464,000
Q1 2023

May 15, 2023

BUY
$565.0 - $694.87 $25,425 - $31,269
45 Added 5.64%
843 $529,000
Q4 2022

Feb 14, 2023

SELL
$551.1 - $688.5 $44,639 - $55,768
-81 Reduced 9.22%
798 $446,000
Q3 2022

Nov 14, 2022

BUY
$545.43 - $680.3 $16,362 - $20,409
30 Added 3.53%
879 $497,000
Q2 2022

Aug 15, 2022

BUY
$605.0 - $763.25 $12,100 - $15,265
20 Added 2.41%
849 $534,000
Q1 2022

May 16, 2022

SELL
$601.4 - $763.0 $21,049 - $26,705
-35 Reduced 4.05%
829 $591,000
Q4 2021

Feb 14, 2022

SELL
$650.15 - $802.0 $5,201 - $6,416
-8 Reduced 0.92%
864 $609,000
Q3 2021

Nov 15, 2021

SELL
$594.24 - $758.0 $158,662 - $202,386
-267 Reduced 23.44%
872 $608,000
Q2 2021

Aug 16, 2021

SELL
$582.88 - $670.99 $8.01 Million - $9.22 Million
-13,739 Reduced 92.34%
1,139 $707,000
Q1 2021

May 17, 2021

SELL
$619.2 - $736.0 $211,766 - $251,712
-342 Reduced 2.25%
14,878 $9.54 Million
Q4 2020

Feb 12, 2021

BUY
$576.6 - $672.2 $260,623 - $303,834
452 Added 3.06%
15,220 $9.77 Million
Q3 2020

Nov 16, 2020

BUY
$620.1 - $689.89 $1.7 Million - $1.89 Million
2,737 Added 22.75%
14,768 $9.25 Million
Q2 2020

Aug 14, 2020

BUY
$610.05 - $713.9 $353,218 - $413,348
579 Added 5.06%
12,031 $7.66 Million
Q1 2020

May 15, 2020

SELL
$615.5 - $751.4 $4.23 Million - $5.17 Million
-6,879 Reduced 37.53%
11,452 $7.44 Million
Q4 2019

Feb 14, 2020

BUY
$688.5 - $846.15 $1.91 Million - $2.35 Million
2,781 Added 17.88%
18,331 $13.8 Million
Q3 2019

Nov 14, 2019

SELL
$722.04 - $840.0 $1.45 Million - $1.68 Million
-2,002 Reduced 11.41%
15,550 $12.1 Million
Q2 2019

Aug 14, 2019

SELL
$837.83 - $927.0 $9.05 Million - $10 Million
-10,800 Reduced 38.09%
17,552 $15 Million
Q1 2019

May 15, 2019

BUY
$709.9 - $885.4 $7.59 Million - $9.46 Million
10,687 Added 60.5%
28,352 $24.9 Million
Q4 2018

Feb 14, 2019

SELL
$667.94 - $785.7 $2.24 Million - $2.63 Million
-3,352 Reduced 15.95%
17,665 $13.1 Million
Q3 2018

Nov 14, 2018

BUY
$602.8 - $699.6 $2.68 Million - $3.11 Million
4,444 Added 26.81%
21,017 $14.6 Million
Q2 2018

Aug 14, 2018

SELL
$568.25 - $635.8 $5.25 Million - $5.88 Million
-9,242 Reduced 35.8%
16,573 $9.93 Million
Q1 2018

May 15, 2018

BUY
$526.8 - $633.85 $11 Million - $13.3 Million
20,931 Added 428.56%
25,815 $16.3 Million
Q4 2017

Feb 12, 2018

BUY
$620.6 - $689.35 $555,437 - $616,968
895 Added 22.44%
4,884 $3.08 Million
Q3 2017

Nov 07, 2017

BUY
$608.7 - $680.0 $2.43 Million - $2.71 Million
3,989
3,989 $2.68 Million

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.